Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Heterocyclic compounds from Sankyo act as Th1-selective immunosuppressants

March 2, 2001

Treatment of T-cell-mediated diseases with new quinazoline derivatives

Feb. 26, 2001

Nabi StaphVAX elicits antibodies against resistant S. aureus strains

Feb. 26, 2001

Improved nucleoside immunomodulators in the ICN pipeline

Feb. 22, 2001

Chlamydia polypeptide and use in DNA vaccines

Feb. 21, 2001

BASB113 polynucleotides and polypeptides for use as vaccines

Feb. 21, 2001

New tuftsin analogues more potent than the parent compound and orally active

Feb. 20, 2001

Pyrimidine-based protein tyrosine kinase inhibitors and their use described by Merck

Feb. 16, 2001

Avax subsidiary to evaluate TK suicide gene therapy technology

Feb. 9, 2001

Genome Therapeutics to identify DNA map of pathogenic organism for Wyeth Lederle Vaccines

Feb. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...